ExLibris header image
SFX Logo
Title: Enhanced Megakaryocyte Apoptosis Corresponds to Higher Platelet Counts in Immune Thrombocytopenia Patients and Increased Proplatelet Formation in Cell Culture
Source:

Blood [0006-4971] Izak, Marina yr:2014


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Machlus, Kellie R. "Protein Synthesis and Degradation in the Late Stages of Megakaryocyte Maturation Trigger Proplatelet Formation." Blood 2012. Link to SFX for this item
2. Kowata, S. "Novel Concept of Platelet Production From Megakaryocyte in Intact Bone Marrow: Proplatelet and Thick Protrusion." Blood 120.21 (2012). Link to SFX for this item
3. Italiano, Joseph E. "High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)-mediated inhibition of platelet production." Blood 120.10 (2012): 1975-1984. Link to SFX for this item
4. Arnold, Donald M M. "Antibody binding to megakaryocytesin vivoin patients with immune thrombocytopenia." European journal of haematology 95.6 (2015): 532-537. Link to Full Text for this item Link to SFX for this item
5. Lev, Paola R. "Impaired proplatelet formation in immune thrombocytopenia: a novel mechanism contributing to decreased platelet count." British journal of haematology 165.6 (2014): 854-864. Link to Full Text for this item Link to SFX for this item
6. Bender, Brendan C. "A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer." Cancer chemotherapy and pharmacology 70.4 (2012): 591-601. Link to Full Text for this item Link to SFX for this item
7. Krop, Ian E. "A Phase II Study of Trastuzumab Emtansine in Patients With Human Epidermal Growth Factor Receptor 2 -Positive Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab, Lapatinib, an Anthracycline, a Taxane, and Capecitabine." Journal of clinical oncology 30.26 (2012): 3234-3241. Link to SFX for this item
8. Kanaji, T. "GPIbα regulates platelet size by controlling the subcellular localization of filamin." Blood (2011): 2906-2913. Link to SFX for this item
9. Alley, Stephen C. "Antibody–drug conjugates: targeted drug delivery for cancer." Current opinion in chemical biology 14.4 (2010): 529-537. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced